(Q43120316)

English

Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons

scientific article published on 10 August 2011

Statements

Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons (English)
1 reference
Nigel Ramsden
1 reference
Jessica Perrin
1 reference
Zhao Ren
1 reference
Byoung Dae Lee
1 reference
Nico Zinn
1 reference
Valina L Dawson
1 reference
Danny Tam
1 reference
Michael Bova
1 reference
Manja Lang
1 reference
Gerard Drewes
1 reference
Marcus Bantscheff
1 reference
Frederique Bard
1 reference
Carsten Hopf
1 reference
10 August 2011
1 reference
6
1 reference
1021-1028
1 reference
10
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit